Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
REVENUES	$ 1,034	$ 415
COST OF REVENUES	739	488
GROSS PROFIT (LOSS)	295	(73)
OPERATING EXPENSES:
Research and development	523	1,125
Selling and marketing	624	634
General and administrative	1,169	1,298
Total operating expenses	2,316	3,057
LOSS FROM OPERATIONS	(2,021)	(3,130)
FINANCIAL EXPENSES (income), net	(43)	77
NET LOSS	$ (1,978)	$ (3,207)
NET LOSS PER SHARE - basic and diluted	$ (0.43)	$ (3.82)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING NET LOSS PER SHARE - basic and diluted	4,623,034	839,533